Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Dirui Industrial

DIRUI Industrial Co., Ltd provides laboratory equipment and clinical diagnostic reagents for the in-vitro diagnostic ... read more Featured Products: More products

Download Mobile App





DIRUI Exhibits Latest Lab Automation Technologies and Devices

By LabMedica International staff writers
Posted on 06 Feb 2024

DIRUI Industrial Co. More...

(Jilin Province, China) is presenting its latest lab automation technologies and devices at Medlab Middle East 2024, including its advanced analyzers for clinical chemistry, urine analysis, and hematology testing.

At Medlab Middle East 2024, DIRUI is showcasing the MUS-3600 urinalysis system featuring four formed element modules that incorporate two urine analysis modules, and has a throughput of up to 480 T/H (for hybrid). It allows up to 580 urine samples to be loaded at one time and features a friendly design with a one-key QC & calibration function. DIRUI is also showcasing the BF-7200 automatic hematology analysis system which can test for 29 parameters, 2 scattergrams and 2 histograms, 7 parameters, 1 scattergram, and 1 histogram. It has a maximum throughput of 480T/H/CBD+DIFF 4 modules and comes with the prompt function of pathology and morphology abnormality alarm.

At the DIRUI booth at Medlab Middle East 2024, visitors can experience the CS-T240Plus fully automated chemistry analyzer which is a powerful desktop device with a constant throughput of 240 tests/ hour and optional ISE throughput of 480 tests/ hour. It performs whole blood testing for HbA1c and delivers accurate results using low minimum reaction volume and saving reagents. The CS-T240Plus has a water consumption of only 3L per hour and features a water quality check function for reliable results.

Related Links:
DIRUI Industrial Co.


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automatic Hematology Analyzer
LABAS F9000
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.